StockWatch
·
Pharmaceuticals
Partnership17 Nov 2026, 03:18 pm

AstraZeneca Pharma India signs LOI with Strand Life Sciences

AI Summary

AstraZeneca Pharma India Ltd has signed a Letter of Intent (LOI) with Strand Life Sciences Private Limited, a subsidiary of Reliance Industries Limited. The collaboration aims to explore opportunities in healthcare within India. Strand Life Sciences is a genomics research and diagnostics company. The companies are not related parties, and the LOI does not constitute a related party transaction. The communication regarding this LOI is available on the company's LinkedIn handle and website.

Key Highlights

  • AstraZeneca Pharma India signs Letter of Intent with Strand Life Sciences.
  • Collaboration focuses on exploring healthcare opportunities in India.
  • Strand Life Sciences is a genomics research and diagnostics company.
  • No related party transaction involved in the LOI.
  • Details disseminated via LinkedIn and company website.